| Home | E-Submission | Sitemap | Editorial Office
top_img
Instructions for Authors > For Authors and Reviewers > Instructions for Authors


1992. 5. 13. Enacted
2016. 12. 14. Revised
2017. 2 22. Revised

The Korean Journal of Critical Care Medicine (Korean J Crit Care Med, KJCCM) is the official scientific journal of the Korean Society of Critical Care Medicine (KSCCM), on the purpose of publishing research and therapeutic achievement in the field of critical care medicine. KJCCM is published quarterly at the end of February, May, August, and November. Manuscripts for submission to KSCCM should be written according to the following instructions for authors. Editorial Board will make the final decision on an approval for the publication of submitted manuscripts and the publication order of accepted manuscripts. Editorial Board reviews ethics, rationality, originality, and scientific significance in accepting submitted manuscripts, and can request any further corrections, revisions, and deletions of the article if necessary. The Korean Journal of Critical Care Medicine follows the Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication, available at: http://www.icmje.org/, if otherwise not described below.

GENERAL INFORMATION

1. Publication Types

The KJCCM focuses on original articles, case reports, reviews, letters to the editor, editorials, and images in critical care.

2. Research Ethics

Clinical research should be done in accordance of the Ethical Principles for Medical Research Involving Human Subjects, outlined in the Helsinki Declaration (http://www.wma.net). All studies (including case reports) of human subjects must contain an appropriate statement within the Materials and Methods or case presentation section indicating approval of the study by the Institutional Review Board (IRB) that subjects have signed written informed consent or that the IRB waived the need for informed consent. Human subjects should not be identifiable, such that patients’ names, initials, hospital numbers, dates of birth, or other protected healthcare information should not be disclosed.
All studies in which animals are used must contain a statement within the Materials and Methods section confirming approval by the Institutional Animal Care and Use Committee (IACUC) and that the care and handling of the animals were in accord with National Institutes of Health (NIH) Guidelines or another appropriate internationally recognized guideline for ethical animal treatment.
The journal adheres to the ethical guidelines for research and publication described in the Council of Science Editors, International Committee of Medical Journal Editors, and World Association of Medical Editors.
Authors who has a financial involvement with any organization or entity with a financial interest in or in financial competition with the subject matter or materials discussed in the manuscript should disclose that affiliation. The manuscript should clearly identify the financial support of the research.

3. Copyright and Publication Ethics

Copyrights ownership is to be transferred to the KSCCM. The authors should submit “Authorship Responsibility and License Agreement Form” at the time of manuscript submission.
All submitted manuscripts should be original and should not be considered by other scientific journals for publication at the same time. Any part of the accepted manuscript should not be duplicated in any other scientific journal without the permission of the Editorial Board. If duplicate publication related to the papers of this journal is detected, the authors will be announced in the journal and their institutes will be informed, and there also will be penalties for the authors.
It is possible to republish manuscripts if the manuscripts satisfy the regulation of secondary publication of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, available at: http://www.icmje.org/.
Authorship credit should be based on (1) substantial contributions to conception and design, acquisition of data or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; (3) final approval of the version to be published; and (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors should meet these 4 conditions. If the number of authors is greater than 6, there should be a list of each author’s role for the submitted paper.

4. Language

Manuscripts are recommended to be written in English. Revised terminology should be written based on the most recent edition of Dorland’s Illustrated Medical Dictionary.

5. Submission of Manuscript

  1. Authors are requested to submit their papers electronically by using the online manuscript submission system, available at: http://submit.kjccm.org/. Under this online system, only corresponding authors and first authors can submit the manuscript. All process of reviewing and editing will be done through this system.
  2. Authors and reviewers may check the progress of reviews and related questions/answers on this system. Every progress in reviews is also informed to corresponding authors.
  3. Upon submission of a manuscript, authors should send a statement of copyright release and author agreement which must be signed by all authors by scanned file to the Editorial Office.
  4. A proof by authors should be submitted within 1 week of the request.

For queries about the manuscript submission, please contact below:

Editorial Office
#806, Yongseong Biztel, 109 Hangang-daero, Yongsan-gu, Seoul 04376, Korea
Tel: +82-2-2077-1533, Fax: +82-2-2077-1535,
E-mail: ksccm@ksccm.org

Jin Publishing & Printing Co.
26 Supyo-ro 6-gil, Jung-gu, Seoul 04554, Korea
Tel: +82-2-2266-7078, Fax: +82-2-2273-8320
E-mail: jinlk@chol.com

6. Peer-review Process

  1. Submitted manuscripts will be reviewed by 2 or more experts in the corresponding field. The Editorial Board may request authors to revise the manuscripts according to the reviewer’s opinion. After revising the manuscript, the author should upload the revised files with a reply to each item of the reviewer’s opinion. The revised part should be marked as red font with underline.
  2. The author’s revisions should be completed within 30 days after the request. If it is not received by the due date, the Editorial Board will not consider it for publication again.
  3. The manuscript review process should be finished the second review. If further revision is requested, the Editorial Board may consider it.
  4. The Editorial Board may request authors to correct English to reach a certain standard and authors should accept the request.

7. Fee for Publication and Reprints

There is no article processing charge. But an additional fee for reprints or color prints will be charged to authors. However, this policy could be changed in the future.

MANUSCRIPT PREPARATION

1. Word Processors and Format of Manuscript

Manuscripts should be submitted in the file format of Microsoft Word 2003 or higher.
Manuscripts should be typed on A4 size, double-spaced, using font size of 12 point with margins of 2 cm on each side and 3 cm for the upper and lower ends. Leave double space between the lines.

2. Abbreviation of Terminology

Abbreviations should be avoided as much as possible. One word should not be expressed as abbreviation and more than two words can be expressed. The full term for which abbreviation stands should be used at its first occurrence in the text. Abbreviations should not be in the title, figure legends, or table titles. Common abbreviations, however, may be used, such as DNA. Abbreviation can be used if it is listed as a MeSH (http://www.ncbi.nlm.nih.gov/mesh).

3. Word-spacing

  1. Leave 1 space for each side, using arithmetic marks as ±, =, +, - (minus), × etc. Ex) 12 ± 1.2
    Leave no space for hyphen between words.
  2. Using parentheses, leave 1 space each side.
  3. Brackets in parentheses, apply square brackets. Ex) ([ ])

4. Citations

  1. If a citation has 2 authors, write as “Smith and Taylor”. If there are more than 3 authors, apply ‘et al.’ at the end of the first author’s surname. Ex) Kim et al. [1].
  2. Citation should be applied after the last word or author’s surname by full-size Arabic numerals on the line and in squre brackets.
    Ex) It is said that hypertension can be brought[1] and the way to injure brain[2] is---
    Ex) Smith et al.[3] reported---
    Ex) Park and Kim[4] reported---
  3. Apply citation before a comma or period. Ex) ---is reported [1], ---is reported [2].
  4. Several or coupled citations can be written as [1,3,5] or [1-5]
    Ex) ---is reported [1,3,5]. ---is reported [1-5].

5. Arrangement of Manuscript

The article should be organized in the order of Title, Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References, Table, Figure, and Figure Legends.
Each new section’s title should begin on a new page. Number pages consecutively, beginning with the abstract page. Page numbers should be placed at the middle of the bottom of page.

6. Organization of Manuscript - Original Articles

1) Cover page

  • Title: Title should be concise and precise. The first letters of noun, adjective, verb, adverb in English title should be capital. The title should use generic drug names, not brand names.
  • Authors and affiliations: The names of the authors contain the first name, middle name, and last name for each author. If the author is affiliated with multiple departments, mark footnotes by the name. If authors are affiliated with multiple departments and hospitals, affiliations should be arranged in the order of authors and assorted with number.
  • Running head: A running head of no more than 50 characters including letters and spaces in English. If inappropriate, the editorial board may revise it.
  • Corresponding author: Name, postal code, address, telephone number, fax number, e-mail address should be written.
  • Conflict of interest: If there are any conflicts of interest, authors should disclose them in the manuscript. If there are no any conflicts of interest, authors should describe following sentence. “No potential conflict of interest relevant to this article was reported".

2) Abstract

All manuscripts should contain a structured abstract. Abstracts should be no more than 250 words in length. It must have following headings: Background, Methods, Results, and Conclusions. Quotation of references is not available in the abstract. A list of keywords, with a maximum of 6 items, should be included at the end of the abstract in alphabetical order and should be written in small alphabetic letters. Each key words should be separated by a semicolon (;) with mark ( . ) at the end of the last word. The authors should use terms from the MeSH.

Ex) Key Words: carbon dioxide; cerebral vessels; oxygen; spinal analgesia.
Ex) Key Words: α2-adrenoceptor agonist; GABA; oxygen.

3) Introduction

The introduction should address the purpose of the article concisely and include background reports that are relevant to the purpose of the paper.

4) Materials and Methods

When reporting experiments with human or animal subjects, the authors should indicate whether they received approval from the IRB for the study, and agreement from the patients. When reporting experiments with animal subjects, the authors should indicate whether the handling of the animals was supervised by Institutional Board for the Care and Use of Laboratory Animals. Sufficient details need to be addressed in the methodology section of an experimental study so that it can be further replicated by others.

  • Units: Laboratory information should be reported in International System of Units [SI], available at http://physics.nists.gov/cuu/Units/index.html or http://physics.nists.gov/Document/sp811.pdf.
  • Exceptions of Units
    1. The unit for volume is “L”, others in “dl, ml, μl”. Ex) 1 L, 5 ml
    2. The units for pressure are mmHg or cmH2O.
    3. Use Celsius for temperature.
    4. Units for concentration are M, mM, μM.
    5. When more than 2 items are presented, diagonal slashes are acceptable for simple units. Negative exponents should not be used. Ex) mg/kg/min [O], mg∙kg-1∙min-1∙[X]
    6. Leave 1 space between number and units except % and ℃. Ex) 5 mmHg. Exception) 5%, 36℃
    7. Units of time
      Ex) hour: 1 h = 60 min = 3600 s, day: 1 d = 24 h = 86400 s
  • Machine and equipment: Provide model name, manufacturer’s name, location of manufacturer (country). Do not put ‘ . ’ between words when writing the names of countries. Ex) U.S.A. [X], USA [O]
  • Drug: Generic names of drugs should be used instead of trade names. If a trade name should be used, insert it in parentheses after the generic name and the manufacturer’s name and country.
  • Ions
    Ex) Na+ [O], Mg2+ [O], Mg++ [X], Mg+2 [X]
  • Statistics: Statistical methods must be described and the program used for data analysis, and its source, should be stated. Summary statistics would define whether standard deviation (± SD) or standard error (± SE) is being used. P values should be expressed to 4 digits.

5) Results

Results should be presented in logical sequence in the text, tables, and illustrations, giving the main or most important findings first. Do not repeat all of the data in the tables or illustrations in the text; emphasize or summarize only the most important observations.

6) Discussion

The discussion should be described to emphasize the new and important aspects of the study, including the conclusions. Do not repeat the results in detail or other information that is given in the Introduction or the Results section. Describe the conclusions according to the purpose of the study but avoid unqualified statements that are not adequately supported by the data. Conclusions may be stated briefly in the last paragraph of the Discussion section.

7) Acknowledgments

Persons or institutes who contributed to the papers but not enough to be co-authors may be introduced at the end (between discussion and reference). Financial support, including foundations, institutions, pharmaceutical and device manufacturers, private companies, or intramural departmental sources, or any other support should be described.

8) References

References should be obviously related to documents and cited in sequential order in the text.
References should be identified in text by full-size Arabic numerals on the line and in square brackets. All of the references should be stated in English, including author, title, name of journal, etc. If necessary, the reviewers and the Editorial Board may request original documents of the references. The range of references are KJCCM, journal registered on ISSN. The journal title should be listed according to the List of Journals Indexed for MEDLINE, available at https://www.nlm.nih.gov/tsd/serials/lsiou.html or the List of KoreaMed Journals, available at: http://koreamed.org.
Six authors can be listed. If more than 6 authors are listed, only list 6 names with ‘et al’. Provide the start and end page numbers of the cited reference. If the numbers in the tens, hundreds, and thousands are same in start and end page, authors should provide only different lower unit numbers as end page.

  • Description format
    A. Journal Article
    Authors. Article title. Journal title Pub¬lished year; Volume: Start-End page.
    1. Kim HS, Park S. Blood transfusion strategies in patients undergoing extracorporeal membrane oxygenation. Korean J Crit Care Med 2017;32:22-8.
    2. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS: defi nitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24.
    3. Orengo CA, Bray JE, Hubbard T, LoConte L, Sillitoe I. Analysis and assessment of abinitio three-dimensional prediction, secondary structure, and contacts prediction. Proteins 1999;43(Suppl 3):149-70.

    B. Book
    Authors. Book title. Edition*. Place of publication: Publisher; Published year.
    *Mark edition if it is beyond the 2nd edition.
    4. Nuwer MR. Evoked potential monitoring in the operating room. 2nd ed. New York: Raven Press; 1986.

    C. Book Chapter
    Authors of chapter. Title of chapter. In: Editors of book, editor(s). Title of book. Edition. Place of publication: Publisher; Published year. p. Start-End page.
    5. Blitt C. Monitoring the anesthseized patient. In: Barash PG, Cullen BF, Stoelting RK, editors. Clinical anesthesia. 3rd ed. Philadelphia: Lippincott-Raven Publishers; 1997. p. 563-85.

    D. Electronic Format
    • Electronic publication before print
      6. Choi Y, Yun MS, Lim SH, Lee J, Ahn JH, Kim YJ, et al. Gemcitabine and docetaxel combination for advanced soft tissue sarcoma: a nationwide retrospective study. Cancer Res Treat 2017 Mar 30 [Epub]. https://doi.org/10.4143/crt.2016.535.
    • Monograph in electronic format
      7. Reeves JR, Maibach H. CDI, clinical dermatology illustrated: a regional approach [CD-ROM]. 2nd ed. Version 2.0. San Diego (CA): CMEA Multi¬media Group; 1995.
    E. PhD thesis
    PhD thesis can not be used as references.

9) Table

Each table should be typed or printed on a separate sheet of paper consecutively in the order of their first citation in the text. Supply a brief title on the top of the table. Title of the table start as “Table 1”. In demographic data, sex would be provided as M/F, and age in year. Data of year, weight, height, and any other units would be provided with 1 decimal place. “±” sign in the upper column of table should be lined up with the lower column. Footnotes should be provided consecutively in order of the informations, statistics and abbreviations. Footnoted information should be referenced using superscript, small letters (ex; a, b) in alphabetical order . Signifi cant diff erences between or among groups should be indicated by * for P < 0.05, ** for P < 0.01, and *** for P < 0.001. Define all abbreviations except those approved by the International System of Units. Define all abbreviations every time they are repeated.

10) Figures and Illustrations

KJCCM publishes in full color, and encourages authors to use color to increase the clarity of figures.
Figures and photographs should be submitted as ‘jpg’ or ‘gif’ files. Contrast of photos or graphs should be at least 600 dpi, contrast of line drawings should be at least 1,200 dpi. Submit files of figures and photographs separately from the text of the paper. Number figures as “Figure Arabic numeral” in the order of their citation (ex. Figure 1). If figure is divided into more than two, mark each figure with Arabic numeral and capital alphabet (Ex. Figure 1A, Figure 1B). Authors should submit line drawings in black and white. In horizontal and vertical legends, the letter of the first English word should be capitalized. Connections between numbers should be denoted by “-”, not “~”. Do not space the numbers (ex. 2-4). Figures should be explained briefly in the titles. An individual should not be recognizable in the photographs or X-ray films unless written consent of the subject has been obtained and is provided at the time of submission. Radiographic prints must have arrows for clarity if applicable. Pathological samples should be pictured with a measuring stick. In microscopic pictures, staining methods and magnification ratio.

11) Legends of Figures and Illustrations

All the figures and photos should be described in the text separately. The description order is the same as in the footnotes in tables and should be in recognizable sentences.

7. Organization of Case Reports

Case reports describe unique and instructive cases that make an important teaching point or scientific observation, novel techniques, use of new equipment, or new information on diseases that are of importance to critical care field. The length of the text excluding references, tables, and figures should not exceed 2,000 words.

  1. Cover page : Same as clinical and experimental studies.
  2. Abstract : Should unstructured and should not exceed 200 words.
  3. Introduction : Should not be separately divided. Briefly describe the case and background without a title.
  4. Case report : Describe only the clinical statement that is directly related to critical care.
  5. Discussion : Briefly discuss the case, and state conclusions at the end of the case. Do not structure the conclusion section separately.
  6. References : Do not exceed 15 references.
  7. Tables and figures : Proportional to clinical and experimental studies.

8. Organization of Reviews

Editorial Board request review articles of particular title and text. Author can describe text not itemized. Review articles should include unstructured abstracts equal to or less than 250 words in English. Key words should follow ordinary process. The length of the text excluding references, tables, and figures should not exceed 5,000 words.

9. Organization of Letters to the Editor

Letters to the Editor should include brief constructive comments that concern a published article, or a short, free-standing opinion or a short interesting case. Letters to the Editor should be submitted no more than 6 months after the paper has been published. Body text should not exceed 2,000 words and should have less than 15 references. Letters may be edited by the Editorial Board and if necessary, responses of the author of the subject paper may be provided. The responses should have same format of Letters to Editor.

10. Images in Critical Care

Images section must be of high scientific quality and of value as well as providing didactic and self-explanatory lessons. They must be unique and adhere to ethical standards with patient/ relative approval when appropriate, protection of patient identity and privacy. The total text should not exceed 300 words. A maximum of five authors is permitted. Up to 5 references are allowed. No abstract is required. The legend to the image should concisely present relevant clinical information, including a short description of the patient’s history, relevant physical and laboratory findings, clinical course, response to treatment (if any), and condition at last follow-up. All labeled structures in the image should be described and explained in the legend.


E-Submission
KJCCM endnote style download
Email Alert
Author's Index
Author's Index
Translation Service
Related society
The Korean Society of Critical Care Medicine
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Directory of Open Access Journals
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
KOFST
COPE
3M
Editorial Office
#806, Yongseong Biztel, 109 Hangang-daero, Yongsan-gu, Seoul 04376, Korea
TEL: +82-2-2077-1533   FAX: +82-2-2077-1535   E-mail: ksccm@ksccm.org
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Society of Critical Care Medicine. All rights reserved.                 developed in m2community
Close layer
prev next